Trials / Completed
CompletedNCT00679237
Risk Reduction in Coronary Heart Disease
Risk Reduction in Coronary Heart Disease - a Prospective Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,600 (actual)
- Sponsor
- Sorlandet Hospital HF · Other Government
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Study hypothesis: Multifactorial risk reduction in coronary heart disease can reduce the risk of new coronary heart disease and death
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | smoking cessation | NRT and varenicline |
| DRUG | betablocker, diuretics, ACEI, ARB, | blood pressure control according to ESC guidelines |
| DRUG | statins, ezetimibe | Cholesterol reduction according to ESC guidelines |
| BEHAVIORAL | training | daily walking |
| BIOLOGICAL | influenza vaccine | vaccine (FLuarix, Influvac etc) |
| DRUG | metformin, glimepiride, insulin | s.glucose control according to ESC guidelines |
| BEHAVIORAL | weight reduction | diet tips |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2008-05-16
- Last updated
- 2021-03-17
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00679237. Inclusion in this directory is not an endorsement.